Altona N.
Altona N.
Altona N., Victoria, Australia4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Phase 2 | 2026-09-22 | NCT07521007 | |
| Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 2 | 2026-09-09 | NCT07497880 | |
| A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain. | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder | Active, not recruiting | Phase 3 | 2026-09-01 | NCT06917404 | |
| Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, familial chylomicronemia syndrome, familial lipoprotein lipase deficiency, hyperlipidemia, hypertriglyceridemia, metabolic disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-30 | NCT06471543 |